Mural Oncology Plc Stock Market Value
| MURA Stock | 3.44 0.20 5.49% |
| Symbol | Mural |
Mural Oncology plc Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mural Oncology. If investors know Mural will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mural Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.03) | Return On Assets (0.81) | Return On Equity (1.78) |
The market value of Mural Oncology plc is measured differently than its book value, which is the value of Mural that is recorded on the company's balance sheet. Investors also form their own opinion of Mural Oncology's value that differs from its market value or its book value, called intrinsic value, which is Mural Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mural Oncology's market value can be influenced by many factors that don't directly affect Mural Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mural Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mural Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mural Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mural Oncology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mural Oncology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mural Oncology.
| 12/28/2022 |
| 12/17/2024 |
If you would invest 0.00 in Mural Oncology on December 28, 2022 and sell it all today you would earn a total of 0.00 from holding Mural Oncology plc or generate 0.0% return on investment in Mural Oncology over 720 days. Mural Oncology is related to or competes with Puma Biotechnology, Iovance Biotherapeutics, Syndax Pharmaceuticals, and Protagonist Therapeutics. Mural Oncology is entity of United States More
Mural Oncology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mural Oncology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mural Oncology plc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.59 | |||
| Information Ratio | 0.0096 | |||
| Maximum Drawdown | 20.93 | |||
| Value At Risk | (5.22) | |||
| Potential Upside | 4.76 |
Mural Oncology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mural Oncology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mural Oncology's standard deviation. In reality, there are many statistical measures that can use Mural Oncology historical prices to predict the future Mural Oncology's volatility.| Risk Adjusted Performance | 0.034 | |||
| Jensen Alpha | 0.0375 | |||
| Total Risk Alpha | (0.23) | |||
| Sortino Ratio | 0.0118 | |||
| Treynor Ratio | 0.1167 |
Mural Oncology plc Backtested Returns
At this point, Mural Oncology is slightly risky. Mural Oncology plc has Sharpe Ratio of 0.0138, which conveys that the firm had a 0.0138% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Mural Oncology, which you can use to evaluate the volatility of the firm. Please verify Mural Oncology's Risk Adjusted Performance of 0.034, mean deviation of 2.16, and Downside Deviation of 2.59 to check out if the risk estimate we provide is consistent with the expected return of 0.0442%. Mural Oncology has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.91, which conveys possible diversification benefits within a given portfolio. Mural Oncology returns are very sensitive to returns on the market. As the market goes up or down, Mural Oncology is expected to follow. Mural Oncology plc right now secures a risk of 3.21%. Please verify Mural Oncology plc semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if Mural Oncology plc will be following its current price movements.
Auto-correlation | -0.04 |
Very weak reverse predictability
Mural Oncology plc has very weak reverse predictability. Overlapping area represents the amount of predictability between Mural Oncology time series from 28th of December 2022 to 23rd of December 2023 and 23rd of December 2023 to 17th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mural Oncology plc price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Mural Oncology price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | -0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.37 |
Mural Oncology plc lagged returns against current returns
Autocorrelation, which is Mural Oncology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mural Oncology's stock expected returns. We can calculate the autocorrelation of Mural Oncology returns to help us make a trade decision. For example, suppose you find that Mural Oncology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mural Oncology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mural Oncology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mural Oncology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mural Oncology stock over time.
Current vs Lagged Prices |
| Timeline |
Mural Oncology Lagged Returns
When evaluating Mural Oncology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mural Oncology stock have on its future price. Mural Oncology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mural Oncology autocorrelation shows the relationship between Mural Oncology stock current value and its past values and can show if there is a momentum factor associated with investing in Mural Oncology plc.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mural Oncology plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mural Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mural Oncology Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mural Oncology Plc Stock:Check out Mural Oncology Correlation, Mural Oncology Volatility and Mural Oncology Alpha and Beta module to complement your research on Mural Oncology. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Mural Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.